The study reveals obesity's role in polypharmacy, indicating that reducing obesity may lower medication burden and enhance ...
A US electronic health record study found that adults with obesity who started semaglutide or tirzepatide had lower recorded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results